Tuesday, April 13, 2021 11:35:48 AM
Imo these stocks (on the OTC) are obviously manipulated.. and by moving the price its easy to scare retail out of the stock (then the selling pressure from those who don't want to lose their gains makes the problem worse)
Imo WDLF has huge potential (I still hold a position) but we have all seen what has happened to almost all of the big recent OTC "winners".. each one imo attacked and brought down 40,50,60 percent or more.
Imo its a push and pull between "how low can they bring it down" VS. the reality of the potential this stock holds.
The naysayers will downplay all the potential:)
But in reality we are getting a piece of all the IPOs and then some.
At some point there will be REAL money in the bank and revenue rolling in.
And THEN it will be a little harder to "discount" the reality and play the "fear" game.
But for now.. its a sh** show. Typical OTC board and OTC players..
Its a shame.. but frankly I'm not surprised.
I personally believe in this management and their long term vision of growing the company (and I like the business model)..
That is why I feel comfortable holding shares for the long term.
We'll see who wins in the end:)
Cy
This is my opinion.. please do your own DD.. this is not investment advice.. I simply try to find the best companies to put my
money.. and I post on boards where I either have an interest in the stock or own shares.
Recent WDLF News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 10:26:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 11:03:18 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 01:57:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 12:50:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/29/2023 02:00:10 PM
- Form D/A - Notice of Exempt Offering of Securities: [Amend] • Edgar (US Regulatory) • 12/08/2023 06:16:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 05:41:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2023 08:13:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2023 10:05:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/20/2023 08:05:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/13/2023 08:52:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2023 01:00:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 01:00:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/22/2023 06:57:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/15/2023 09:25:13 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 12:00:23 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 07/14/2023 08:57:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/07/2023 08:39:16 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM